Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

50.750
-3.150-5.84%
Volume:5.67M
Turnover:292.05M
Market Cap:29.59B
PE:-11.33
High:53.350
Open:53.350
Low:50.400
Close:53.900
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:2.31
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:6.90
PE(LYR):-11.33
PS:27.93

Loading ...

INSILICO Weighs Joining New Investment Fund Initiative

Stock News
·
Aug 18

Insilico Medicine Plans Joint Venture with Pudong Construction to Launch RMB 1.01 Billion Biopharma Fund

Reuters
·
Aug 18

Insilico Medicine Cayman Topco - to Hold 60% of RMB5 Mln Joint Venture Capital

THOMSON REUTERS
·
Aug 18

Insilico Medicine Cayman Topco - Proposed Fund Targets Rmb1.01 Bln for Biopharmaceutical Investments

THOMSON REUTERS
·
Aug 18

Movement Alert|INSILICO Falls 5.24% in Regular Trading, Trading at HKD 42.46

Market Focus
·
Aug 18

Insilico Medicine: Change Will Take Effect as of Close of August 31, 2026

THOMSON REUTERS
·
Aug 17

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths

THOMSON REUTERS
·
Aug 17

Earnings Reports Drive Market Sentiment as Hong Kong Stocks Face Headwinds

Stock News
·
Aug 17

Hong Kong Stock Market News Digest: Key IPO Launches and Mid-Year Financial Results

Stock News
·
Aug 17

Insilico Medicine Secures Spot in MSCI Global Small Cap Indexes Effective 31 Aug 2026

Bulletin Express
·
Aug 17

Insilico Medicine Joins MSCI Global Small Cap Indexes Effective Aug. 31, 2026

Reuters
·
Aug 17

Movement Alert|INSILICO Falls 5.09% in Regular Trading, Trading at HK$43.92

Market Focus
·
Aug 14

Movement Alert|INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm

Market Focus
·
Aug 13

Hong Kong Stock Movements: INSILICO (03696) Rises Over 4% Intraday, Announces Research Collaboration with South Korea's THPharm

Stock News
·
Aug 13

Insilico Medicine Nominates Oral Lp(a) Inhibitor Ism0900 as Preclinical Candidate for Cardiovascular Risk Management

Reuters
·
Aug 12

InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 11

Insilico Medicine Updates Financial Calendar with Interim Earnings Conference Calls

Reuters
·
Aug 11

GTHT Initiates Coverage on INSILICO with "Accumulate" Rating, Setting a Price Target of HKD 73.23

Stock News
·
Aug 10

Movement Alert|INSILICO Rises 9.6% in Regular Trading, NLRP3 Inhibitor Receives Clinical Approval Plus JPMorgan Initiates Coverage

Market Focus
·
Aug 10

Hong Kong Stocks Update | INSILICO Surges Over 9% as ISM8969/HT-001 Receives NMPA Clinical Trial Approval for Parkinson's Disease Treatment

Stock News
·
Aug 07